Comprehensive Care Corporation (CHCR) 0.1400

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Comprehensive Care Corporation (CHCR) 0.1400 $CHCR

Ontario Funds Bundled Care Teams to Improve Patient Experience
M2 - Thu Sep 03, 6:21AM CDT
"We have been privileged to help develop this program through the success of the St. Joseph's Health System Integrated Comprehensive Care Project and are honoured to work with our partners to extend this model in a way that works best locally for them. In health care, when we discover something that improves the patient experience in an efficient model and enables health care providers to feel more confident in the care that they deliver, we know we're onto something. We would like to thank Minister Hoskins for championing this transformative model of care that is truly patient centered."

Navigating Cancer Raises $10 Million to Grow Team and Expand Comprehensive Care and Engagement Platform
PR Newswire - Thu Aug 20, 8:00AM CDT
Navigating Cancer, the leading web-based patient care and engagement solution for cancer programs, announced today the close of a $10 million funding round led by Merck Global Health Innovation Fund in syndicate with ORIX Healthcare Capital, along with existing investor Rustic Canyon Partners.
MRK: 52.09 (-0.63)

Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. and Its Wholly-Owned Subsidiary, National Sleep Specialists Network, Inc., Signs Agreement with U.S. HealthWorks Medical Group Prof. Corp.
PR Newswire - Mon Jul 27, 11:15AM CDT
Advanzeon Solutions, Inc.'s (OTC-BB: CHCR), (Advanzeon) wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. (PVMS), and its wholly-owned subsidiary, National Sleep Specialists Network, Inc. (NSSN) (collectively, sometimes referred to as the "Company", announced today the signing of an Agreements with U.S. HealthWorks Medical Group Prof. Corp. ("U.S. HealthWorks" whereby U.S. HealthWorks agreed to add its over 200 medical locations specializing in occupational medicine, medical examinations and urgent care services to NSSN's growing national provider healthcare network, specializing in sleep apnea programs. This agreement is effective immediately.

Advanzeon Solutions, Inc. Expands Service Territory with Nevada Health CO-OP
PR Newswire - Wed Jul 08, 9:41AM CDT
Advanzeon Solutions, Inc.'s (OTC-BB: CHCR), ("Advanzeon" or the "Company" announced today that it has entered into an addendum (the "Addendum" to its Memo of Understanding ("MOU" with the Nevada Health CO-OP (the "CO-OP" (see the Company's announcement dated February 25, 2015). The Addendum enlarges the territory being serviced by Advanzeon in order to include all members of the CO-OP throughout the State of Nevada, and it extends the term of the MOU for the Company's behavioral health services to December 31, 2015.

Comprehensive Care Essential for More Effective Addiction Treatment, Reveals Chapters Capistrano
M2 - Tue Jul 07, 7:01AM CDT
In order to meet the diverse needs of clients and address the wide range of issues associated with addiction, Chapters Capistrano encourages comprehensive treatment plans.

Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Has Successfully Launched Its Sleep Apnea Program For Southern California Teamsters
PR Newswire - Mon Jul 06, 10:04AM CDT
Advanzeon Solutions, Inc.'s (OTC-BB: CHCR), (Advanzeon) wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. (PVMS) (collectively, sometimes referred to as the "Company" announced today that, pursuant to its Agreement with the Trustees of a large Teamsters Health and Welfare Fund in Southern California (see our announcement of June 3, 2015), PVMS has successfully launched operations of its Sleep Apnea Program (the "Program" for the Southern California Teamsters.

Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division
GlobeNewswire - Mon Jun 29, 10:03AM CDT
via PRWEB - Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced the promotion of two leaders with the Commercial Markets division, which includes the company's commercial health plan portfolio of products and services for individuals, small and large employers, and Minnesota-headquartered companies with regional, national and international reach. Mary Ellen Anderson now holds the title of vice president, president of Comprehensive Care Services, Inc. (CCStpa). Sandy Hill had been named as vice president, commercial markets, sales operations and shared services.

Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Signs Agreement With Southern California Teamsters
PR Newswire - Wed Jun 03, 8:38AM CDT
Advanzeon Solutions, Inc.'s (OTC-BB: CHCR), ("Advanzeon" wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS", announced today that it has entered into an agreement with the Trustees of a large Teamsters Health and Welfare Fund in Southern California (the "Teamsters Trust Fund". The Agreement provides, among other things, for PVMS to provide sleep apnea testing and treatment through its SleepMaster Solutions(TM) Program to the Teamsters Trust Fund members operating commercial vehicles in California. The Program becomes effective July 1, 2015 and has an initial three-year term.

Advanzeon Solutions, Inc. And Its Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Welcome Major League Baseball Great Matt Capps As Senior Public Relations Consultant
PR Newswire - Tue May 26, 9:01AM CDT
Advanzeon Solutions, Inc. (OTC:BB: CHCR), ("Advanzeon" and its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS", (sometimes, collectively referred to as the "Company", announced today that effective immediately Mr. Matt Capps has joined the Company's team as its Senior Public Relations Consultant to the Company's Community Outreach Programs. Mr. Capps has also taken a financial position in Advanzeon. This engagement provides for Mr. Capps to form a vital link for the Company to the communities in which the Company operates. Mr. Capps will assist the Company in achieving maximum results from Community Outreach Programs designed to not only enhance the stature of the Company, but to further enhance the quality of life in those communities.

Advanzeon Solutions, Inc. Announces the Appointment of James L. Koenig to its Board of Directors
PR Newswire - Mon May 11, 10:27AM CDT
Advanzeon Solutions, Inc. (OTCBB: CHCR), ("Advanzeon" or the "Company" is pleased to announce that James L. Koenig has been appointed to serve on the Company's Board of Directors, effective immediately. Mr. Koenig has functioned as the Company's Acting Chief Financial Officer since December, 2013.

Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe And Effective In Patients With Multiple Sclerosis
PR Newswire - Mon Apr 20, 7:05PM CDT
Extending the dose of an infusion medication for multiple sclerosis (MS) from 4 weeks up to 8 has been shown to be well-tolerated and effective -- and resulted in no cases of the potentially fatal side effect, progressive multifocal leukoencephalopathy (PML), according to a new study led by researchers at NYU Langone Medical Center.

Advanzeon Solutions, Inc. Elects Gerard T. Smith as its Chief Operating Officer
PR Newswire - Tue Apr 07, 6:48AM CDT
Advanzeon Solutions, Inc. (OTCBB: CHCR) ("Advanzeon" or the "Company", which provides behavioral health, substance abuse and pharmacy management services, as well as sleep apnea programs, to employers, Taft-Hartley health and welfare funds and managed care companies throughout the U.S., announced today that Gerard T. Smith has agreed to join the Company as its new Chief Operating Officer (COO), effective immediately. Mr. Smith has also agreed to serve as the COO of Pharmacy Value Management Services, Inc. (PVMS), the Company's wholly owned subsidiary in pharmacy management services, as well as sleep apnea programs (the Company and PVMS will collectively be referred to as the "Company".

/C O R R E C T I O N -- Advanzeon Solutions, Inc./
PR Newswire - Mon Dec 29, 2:56PM CST
In the news release, Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Strengthens Marketing Position for Its Sleep Apnea Program By Signing Agreement with CPAP Supply USA, LLC, issued 29-Dec-2014 by Advanzeon Solutions, Inc. over PR Newswire, we are advised by the company that the fourth paragraph, third sentence, should read "It is a philosophy that we understand is shared with us by PVMS as well" rather than "It is a philosophy that we understand is shared with us buy PVMS as well" as originally issued inadvertently ("by" not "buy". The complete, corrected release follows:

Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Strengthens Marketing Position for Its Sleep Apnea Program By Signing Agreement with CPAP Supply USA, LLC
PR Newswire - Mon Dec 29, 8:31AM CST
Advanzeon Solutions, Inc. (OTC:BB:CHCR), ("Advanzeon" or the "Company", which provides behavioral health, wellness, pharmacy management services and sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. today announced that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS", has entered into an agreement (the "Agreement" with CPAP Supply USA, LLC ("CPAP Supply USA". The Agreement provides for, among other things, "most-favored nation pricing," market protection and complete, full-line product support. The Agreement is effective immediately and marketing programs have already been put in place for implementation.

Advanzeon Solutions, Inc. Signs Agreement Expanding Its Software And Technological Capabilities
PR Newswire - Wed Dec 03, 9:00AM CST
Advanzeon Solutions, Inc. (OTC:BB: CHCR), ("Advanzeon" or the "Company", which provides behavioral health, substance abuse and pharmacy management services, as well as sleep apnea programs, to employers, Taft-Hartley health and welfare funds, and managed care companies throughout the U.S. is pleased to announce that it has entered into an Agreement with WLT Software Enterprises, Inc. ("WLT". The Agreement provides, in pertinent part, that WLT will make their "MediClaims" software available to Advanzeon. The Agreement is effective immediately and implementation commenced on December 2, 2014.

Advanzeon Solutions, Inc. Retains Lisa Smithers as Vice President/Director of Operations
PR Newswire - Mon Oct 27, 6:28AM CDT
Advanzeon Solutions, Inc. (OTC:BB: CHCR), ("Advanzeon" or the "Company", which provides behavioral health, substance abuse and pharmacy management services, as well as sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. is pleased to announce that Lisa Smithers has been named as Advanzeon's Vice President/Director of Operations. Ms. Smithers will report directly to Mark Heidt, the Company's President.

Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Signs Marketing Agreement With Jeff Liva & Co.
PR Newswire - Mon Sep 29, 2:28PM CDT
Advanzeon Solutions, Inc. (OTC:BB: CHCR), ("Advanzeon" or the "Company", which provides behavioral health, wellness, pharmacy management services and sleep apnea programs, to employers, Taft-Hartley health and welfare funds, managed care companies throughout the U.S. today announced that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS", has entered into a marketing agreement (the "Agreement" with Jeff Liva & Co. ("Dr. Liva", whereby Dr. Liva, through his Preventive PLUS division will, among other things, introduce the Company's programs to his existing and potential clients and recommend the programs for inclusion in his clients' healthcare benefit packages. Forming the subject matter of the Agreement are PVMS' sleep apnea and pharmacy management services programs, and its parent company's behavioral health and wellness programs (collectively, the "Programs". The Agreement became effective immediately upon signing last week and joint efforts between the two companies are set to commence this week.

Without Teens in Cancer Trials, Cure Rates Won't Improve
PRWeb - Sun Sep 28, 2:12AM CDT
Between "The Fault in Our Stars," and "Red Band Society," it seems that stories of teenagers with cancer are suddenly everywhere. But as Evidence-Based Oncology, a publication of The American Journal of Managed Care, outlines in its current issue, the teen cancer story that needs to be told is the one that might save more lives: why aren't more teens and young adults with cancer enrolled in clinical trials?

Perkins Eastman Celebrates Ribbon Cutting of Tulsa Jewish Retirement and Health Center in Tulsa, OK
PRWeb - Fri Sep 19, 3:01PM CDT
Today the Tulsa Jewish Retirement & Health Center in Tulsa, Oklahoma, cut the ceremonial ribbon on recent renovations and several strategic additions to its continuum of care community. The crown jewel of this two-and-a-half year project is the brand new Scott F. Zarrow Town Center, which will become the Tulsa intergenerational community's new central gathering space, including an open floor plan with lobby, café, multi-purpose room, and expansive views. Designed by Perkins Eastman and led by Principals Dan Cinelli FAIA, Jerry Walleck AIA, and Associate Nathaniel Koschmann AIA, LEED AP, the team's approach was to maximize the reuse of existing building shells and systems while giving the overall community an inviting hospitality-focused look and environmentally sustainable features.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading